‘Skinny Label’ Litigation: Generic Firms Rethinking Strategy, May Pursue Legislation

 
• By Brenda Sandburg
  
Skinny label
Litigation over generic drug skinny labels will remain a trendy topic in 2022. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pink Sheet Perspectives

More from Pink Sheet